53 related articles for article (PubMed ID: 7087714)
1. [Effect of bupranolol in combination with isosorbide dinitrate in bronchial diseases].
Buchegger G; Vankov T
Med Welt; 1982 Mar; 33(10):376-8. PubMed ID: 7087714
[No Abstract] [Full Text] [Related]
2. [Isosorbide dinitrate and bupranolol in the therapy of coronary heart disease (author's transl)].
Pascal N; Eggert R
Arzneimittelforschung; 1978; 28(5):847-50. PubMed ID: 373775
[TBL] [Abstract][Full Text] [Related]
3. [The immediate effect of beta-isoket on the internal ocular pressure in patients with chronic simple glaucoma (author's transl)].
Oancea I
Klin Monbl Augenheilkd; 1975 Oct; 167(4):618-22. PubMed ID: 1574
[TBL] [Abstract][Full Text] [Related]
4. [Patient compliance with a free and fixed combination of isosorbide dinitrate and bupranolol].
Gill E; Bechler M; Forst HT
ZFA (Stuttgart); 1980 May; 56(14):1037-44. PubMed ID: 7415470
[No Abstract] [Full Text] [Related]
5. [Treatment of coronary insufficiency. Comparative study on the effect of a nitro compound (isosorbidedinitrate), a beta sympatholytic (bupranolol) and a drug combination (oxycardin)].
Philipp R; Kutscha W
Med Welt; 1980 May; 31(21):817-20. PubMed ID: 7392937
[No Abstract] [Full Text] [Related]
6. [Experiences with isosorbide dinitrate in combination with a beta receptor blockader (Bupranolol)].
Bernat AC; Riera de Barcia L
Med Monatsschr; 1976 Oct; 30(10):470-3. PubMed ID: 10516
[No Abstract] [Full Text] [Related]
7. [Clinical experiences with the Kö 1366 (Bunitrololhydrochloride) beta receptor blockader and the combination Kö 1366/Isosorbitdinitrate in patients with coronary disease].
Holzhey P
Wien Med Wochenschr; 1975 Oct; 125(42-44):624-9. PubMed ID: 5819
[No Abstract] [Full Text] [Related]
8. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
Mahgoub AA; El-Medany AH; Abdulatif AS
Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
[TBL] [Abstract][Full Text] [Related]
9. [On the inhibition of thrombocyte aggregation by bupranolol / Aggregometric and electron microscopic study in vitro (author's transl)].
Zwillenberg LO; Bösiger G
Arzneimittelforschung; 1980; 30(3):483-7. PubMed ID: 7387760
[TBL] [Abstract][Full Text] [Related]
10. [Studies of bupranolol therapy for glaucoma. 1. Ocular penetration and hypotensive effect (author's transl)].
Komuro S; Nanba H; Takase M
Nippon Ganka Gakkai Zasshi; 1979 Jun; 83(6):537-41. PubMed ID: 484390
[No Abstract] [Full Text] [Related]
11. [Therapy of hyperdynamic disorders of the cardio-circulatory system with bupranolol chlorhydrate].
Marsala F
Clin Ter; 1983 May; 105(4):323-31. PubMed ID: 6347503
[No Abstract] [Full Text] [Related]
12. [Combination of proteolytic enzymes and antibiotics in the therapy of chronic bronchial diseases].
Mazza V; Molè R; Sessa G; Pennarola R
Folia Med (Napoli); 1969 Sep; 52(9):565-78. PubMed ID: 5401773
[No Abstract] [Full Text] [Related]
13. Isosorbide dinitrate or nifedipine: which is preferable in the medical therapy of achalasia?
Bortolotti M; Coccia G; Brunelli F; Sarti P; Mazza M; Bagnato F; Barbara L
Ital J Gastroenterol; 1994; 26(8):379-82. PubMed ID: 7703511
[TBL] [Abstract][Full Text] [Related]
14. Isosorbide dinitrate spray as therapeutic strategy for treatment of chronic venous ulcers.
Sánchez-Vázquez R; Briseño-Rodríguez G; Cardona-Muñoz EG; Gálvez-Gastélum FJ; Totsuka-Sutto SE; Garcia-Benavides L
Angiology; 2008; 59(1):64-71. PubMed ID: 18319224
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of sublingual isosorbide dinitrate and cardiomyotomy on esophageal emptying in patients with chagasic megaesophagus.
de Oliveira RB; Matsuda NM; Figueiredo Mdo C; Okano N; Vargas EC
Arq Gastroenterol; 1994; 31(2):47-51. PubMed ID: 7872864
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the pharmacodynamics and pharmacokinetics of two oral sustained-release formulations of isosorbide dinitrate in normal man.
Johnson KI; Gladigau V; Schnelle K
Arzneimittelforschung; 1981; 31(6):1026-9. PubMed ID: 7196234
[TBL] [Abstract][Full Text] [Related]
17. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
[TBL] [Abstract][Full Text] [Related]
18. [Hemodynamic effect of sublingual isosorbide dinitrate in acute myocardial infarct].
Coma Canella I; López Sendón J; Barahona P; Martin Jadraque L
Rev Esp Cardiol; 1980; 33(1):71-9. PubMed ID: 7384599
[No Abstract] [Full Text] [Related]
19. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
[TBL] [Abstract][Full Text] [Related]
20. Peripheral resistances in acute myocardial infarction: the use of prazosine versus isosorbide dinitrate.
Costa PP; Permutti B; Fernandes P; Croce G
Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):208-11. PubMed ID: 7390671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
